CDK4 and cancer: mTOR signaling may promote the survival of cancer cells via enhancing the expression of FANCD2, CHK1 and RRM2 through CDK4/6 while inhibiting ATM, revealing the potential mechanisms of the increased cancer cell growth and proliferation under stressful conditions21,23,24,26.